Changes in quality of life in patients with breast cancer
10.1111/j.1365-2702.2010.03422.x · 2011
Cluster of symptoms in women with breast cancer treated with curative intent
10.1007/s00520-011-1238-1 · 2012
Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians’ and nurses’ estimation vs. patients’ reported outcomes
10.1007/s00520-005-0788-5 · 2005
Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide
10.1345/aph.1l437 · 2009
Unresolved referenced work
2005
Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study
10.1007/s00520-010-1073-9 · 2012
Understanding the concept of chemotherapy-related nausea: the patient experience
10.1111/j.1365-2354.2007.00872.x · 2008
DNA methylation and personalized medicine
10.1111/jcpt.12206 · 2014
Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy
2003
Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism
10.1002/ijc.10793 · 2003
Managing the innovation supply chain to maximize personalized medicine
10.1038/clpt.2013.228 · 2014
New strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs
10.1158/1078-0432.ccr-13-0753 · 2014
Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting
10.1056/nejmra1515442 · 2016
Variations in self-reported nausea, vomiting, and well-being during the first 10days postchemotherapy in women with breast cancer
10.1188/14.cjon.e32-e36 · 2014
Svenska Emesisregistret stärker kvaliteten i behandling av illamående vid kemoterapi
2009
Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients
10.1200/jco.2003.05.164 · 2003
Apoptosis: a link between cancer genetics and chemotherapy
10.1016/s0092-8674(02)00625-6 · 2002
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
10.1517/14656566.2013.776541 · 2013
Targeting the checkpoint kinases: chemosensitization versus chemoprotection
10.1038/nrc1296 · 2004
Pharmacogenetics of chemotherapy-induced nausea and vomiting
10.2217/pgs.14.168 · 2015
Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
10.1186/1744-8069-4-64 · 2008
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids
10.1016/j.ejca.2011.04.014 · 2011
Genetic variations of drug transporters can influence on drug response in patients treated with docetaxel chemotherapy
10.4143/crt.2014.012 · 2015
A sharper Bonferroni procedure for multiple tests of significance
10.1093/biomet/75.4.800 · 1988
More powerful procedures for multiple significance testing
10.1002/sim.4780090710 · 1990
Insight in the prediction of chemotherapy-induced nausea
10.1007/s00520-009-0723-2 · 2010
Neuropharmacology and management of chemotherapy-induced nausea and vomiting in patients with breast cancer
10.1159/000366300 · 2014
Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial
10.1188/07.onf.813-820 · 2007
Keeping it in the family: the impact of marital status and next of kin on cancer treatment and survival
10.1016/j.amjsurg.2016.07.004 · 2016
Marital status and colon cancer outcomes in US surveillance, epidemiology and end results registries: does marriage affect cancer survival by gender and stage?
10.1016/j.canep.2011.02.004 · 2011
Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance)
10.1007/s00520-016-3080-y · 2016
Effect of increase in duration of aprepitant consumption from 3 to 6days on the prevention of nausea and vomiting in women receiving combination of anthracycline/cyclophosphamide chemotherapy: a randomized, crossover, clinical trial
10.4103/2277-9175.168605 · 2015
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
10.1084/jem.20141836 · 2015
The role of CD95 and CD95 ligand in cancer
10.1038/cdd.2015.25 · 2015
Common variants in RB1 gene and risk of invasive ovarian cancer
10.1158/0008-5472.can-06-2222 · 2006
A simulated SNP experiment indicates a high risk of over-fitting and false positive results when a predictive multiple SNP model is established and tested within the same dataset
10.1016/j.radonc.2015.02.004 · 2015
